Recent Advances in Mineralocorticoid Receptor Antagonists

Annual Reports in Medicinal Chemistry

Volumn 46, Issue , 2011, Pages 89-102

  Leftheris, Katerina ^a   Zheng, Yajun ^a   Lala, Deepak S ^a  

^a Vitae Pharmaceuticals   (United States)

Author keywords

Calcium channel blockers; Diabetic nephropathy; Hypertension; Nuclear hormone receptor; Steroid receptor

Indexed keywords

EID: 80054120294     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386009-5.00021-7     Document Type: Chapter

References (50)

1. Mangelsdorf D.J., Thummel C., Beato M. Cell 1995, 83:835.
2. Viengchareun S., Menuet D.L., Martinerie L., Munier M., Pascual-Le Tallec L., Lombès M. Nucl. Recept. Signal. 2007, 5:e012.
3. Rocha R., Stier C.T., Kifor I., Ochoa-Maya M.R., Rennke H.G., Williams G.H., Adler G.K. Endocrinology 2000, 141:3871.
4. Weber K.T. N. Engl. J. Med. 2001, 345:1689.
5. Rocha R., Rudolph A.E., Frierdich G.E., Nachowiak D.A., Kekec B.K., Blomme E.A., McMahon E.G., Delyani J.A. Am. J. Physiol. Heart Circ. Physiol. 1802, 2002:283.
6. Blasi E.R., Rocha R., Rudolph A.E., Blomme E.A., Polly M.L., McMahon E.G. Kidney Int. 2003, 63:1791.
7. Funder J.W. Prog. Cardiovasc. Dis. 2010, 52:393.
8. Stier C.T., Chander P.N., Rocha R. Cardiol. Rev. 2002, 10:97.
9. Maron B.A., Leopold J.A. Curr. Opin. Invest. Drugs 2008, 9:963.
10. Calhoun D.A. Circulation 2006, 114:2572.
11. Beygui F. Circulation 2006, 114:2604.
12. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., Evans R.M. Science 1987, 237:268.
13. George G., Struthers A.D. Expert Opin. Pharmacother. 2007, 8:13053.
14. Rogerson F.M., Dimopoulos N., Sluka P., Chu S., Curtis A.J., Fuller P.J. J. Biol. Chem. 1999, 274:36305.
15. Viengchareun S., Menuet D.L., Martinerie L., Munier M., Pascual-Le Tallec L., Lombès M. Nuc. Recept. Signal. 2007, 5:e012.
16. Hultman M.L., Krasnoperova N.V., Li S., Du S., Xia C., Dietz J.D., Lala D.S., Welsch D.J., Hu X. Mol. Endocrinol. 2005, 19:1460.
17. Vijayaraghavan K., Deedwania K.P. Cardiol. Clin. 2011, 29:137.
18. Fagart J., Hillisch A., Huyet J., Baerfacker L., Fay M., Pleiss U., Pook E., Schaefer S., Rafestin-Oblin M.E., Kolkhof P. J. Biol. Chem. 2010, 285:29932.
19. Weinberger M.H. Am. Heart J. 2005, 150:426.
20. Nishizaka M.K. Am. J. Hypertens. 2003, 6:925.
21. Pitt B. N. Engl. J. Med. 1999, 341:709.
22. Pitt B., Bakris G., Ruilope L.M., DiCarlo L., Mukherjee R. Circulation 2008, 118:1643.
23. Zannad F. N. Engl. J. Med. 2011, 364:11.
24. Armstrong P.W. N. Engl. J. Med. 2011, 364:1.
25. Mehdi J. Am. Soc. Nephrol. 2009, 20:2641.
26. Bledsoe R.K., Madauss K.P., Holt J.A., Apolito C.J., Lambert M.H., Pearce K.H., Stanley T.B., Stewart E.L., Trump R.P., Willson T.M., Williams S.P. J. Biol. Chem. 2005, 280:31283.
27. Fagart J., Huyet J., Pinon G.M., Rochel M., Mayer C., Rafestin-Oblin M.E. Nat. Struct. Mol. Biol. 2005, 12:554.
28. Li Y., Suino K., Daugherty J., Xu H.E. Mol. Cell 2005, 19:367.
29. Huyet J., Pinon G.M., Fay M.R., Fagart J., Rafestin-Oblin M.E. Mol. Pharmacol. 2007, 72:563.
30. Hu X., Funder J.W. Mol. Endocrinol. 2006, 20:1471.
31. Huang P., Chandra V., Rastinejad F. Ann. Rev. Physiol. 2010, 72:247.
32. Geller D.S., Farhi A., Pinkerton N., Fradley M., Moritz M., Spitzer A., Meinke G., Tsai F.T., Sigler P.B., Lifton R.P. Science 2000, 289:119.
33. Rafestin-Oblin M.E., Souque A., Bocchi B., Pinon G., Fargt J., Vandewalle A. Endocrinology 2003, 144:528.
34. Pinon G.M., Fagart J., Souque A., Auzou G., Vandewalle A., Rafestin-Oblin M.E. Mol. Cell. Endocrinol. 2004, 217:181.
35. Dietz J.D., Du S., Bolten C.W., Payne M.A., Xia C., Blinn J.R., Funder J.W., Hu X. Hypertension 2008, 51:742.
36. Arhancet G.B., Woodard S.S., Dietz J.D., Garland D.J., Wagner G.M., Iyanar K., Collins J.T., Blinn J.R., Numann R.E., Hu X., Huang H.C. J. Med. Chem. 2010, 53:4300.
37. Rovnyak G.C., Kimball S.D., Beyer B., Cucinotta G., DiMarco J.D., Gougoutas J., Hedberg A., Malley M., McCarthy J.P. J. Med. Chem. 1995, 38:119.
38. Arhancet G.B., Woodard S.S., Iyanar K., Case B.L., Woerndle R., Dietz J.D., Garland D.J., Collins J.T., Payne M.A., Blinn J.R., Pomposiello S.I., Hu X., Heron M.I., Huang H.C., Lee L.F. J. Med. Chem. 2010, 53:5970.
39. Brandish P.E., Fraley M.E., Hershey J.C., Steen J.T. Patent Application WO 2009/078934 2009.
40. Meyers M.J., Arhancet G.B., Hockerman S.L., Chen X., Long S.A., Mahoney M.W., Rico J.R., Garland D.J., Blinn J.R., Collins J.T., Yang S., Huang H.C., McGee K.F., Wendling J.M., Dietz J.D., Payne M.A., Homer B.L., Heron M.I., Reitz D.B., Hu X. J. Med. Chem. 2010, 53:5979.
41. Arhancet G.B., Casimiro-Garcia A., Chen X., Hepworth D., Meyers M.J., Piotrowski W., Raheja R.K. Patent Application WO 2010/11628 2010.
42. Fukumoto S., Ohyabu N., Ohra T., Sugimoto T., Hasui T., Fuji K., Siedem C., Gauthier C. Patent Application US 2010/0094000 2010.
43. Bell M.G., Gernert D.L., Grese T.A., Belvo M.D., Borromeo P.S., Kelley S.A., Kennedy J.H., Kolis S.P., Lander P.A., Richey R., Sharp V.S., Stephenson G.A., Williams J.D., Yu H., Zimmerman K.M., Steinberg M.I., Jadhav P.K. J. Med. Chem. 2007, 50:6443.
44. Brandish P.E., Chen H., Szczerba P., Hershey J.C. J. Pharmacol. Toxicol. Methods 2008, 57:155.
45. Brandish P.E., Hershey J.C., Fraley M.E., Steen J.T. Patent Application WO 2008118319 2008.
46. Coates D.A., Gavardinas K., Jadhav P.K. Patent Application WO 2010/104721 2010.
47. Michellys P., Petrassi H.M., Richmond W., Pei W. Patent Application WO 2006/015259 2006.
48. Fukumoto S., Matsunaga N., Ohra T., Ohyabu N., Hasui T., Motoyaji T., Takashi S., Stephen C., Tang T., Pisal D., Demeese L.A., Gauthier C. Patent Application WO 2007/077961 2007.
49. Brown J.W., Gangloff A.R., Kiryanov A.A. Patent Application WO 2011/014681 2011.
50. Fukumoto S., Ohyabu N., Ohra T., Sugimoto T., Hasui T., Fuji K., Siedem C.S., Gauthier C. Patent Application US 2010/0094000 2010.